Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity (DOI: 10.1016/j.immuni.2008.04.020)

Diana Chessman, Lyudmila Kostenko, Tessa Lethborg, Anthony W. Purcell, Nicholas A. Williamson, Zhenjun Chen, Lars Kjer-Nielsen, Nicole A. Mifsud, Brian D. Tait, Rhonda Holdsworth, Coral Ann Almeida, David Nolan, Whitney A. Macdonald, Julia K. Archbold, Anthony D. Kellerher, Debbie Marriott, Simon Mallal, Mandvi Bharadwaj, Jamie Rossjohn, James McCluskey

Research output: Contribution to journalComment / DebateOtherpeer-review

1 Citation (Scopus)
Original languageEnglish
Number of pages1
JournalImmunity
Volume29
Issue number1
DOIs
Publication statusPublished - 18 Jul 2008

Cite this

Chessman, D., Kostenko, L., Lethborg, T., Purcell, A. W., Williamson, N. A., Chen, Z., Kjer-Nielsen, L., Mifsud, N. A., Tait, B. D., Holdsworth, R., Almeida, C. A., Nolan, D., Macdonald, W. A., Archbold, J. K., Kellerher, A. D., Marriott, D., Mallal, S., Bharadwaj, M., Rossjohn, J., & McCluskey, J. (2008). Human Leukocyte Antigen Class I-Restricted Activation of CD8+ T Cells Provides the Immunogenetic Basis of a Systemic Drug Hypersensitivity (DOI: 10.1016/j.immuni.2008.04.020). Immunity, 29(1). https://doi.org/10.1016/j.immuni.2008.06.002